Skeletal Effects of Carcinoma of the Breast and Prostate
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Recent research has led to improved understanding of the pathology of skeletal metastases in carcinoma of the breast and prostate. Several humoral mechanisms have been identified which have both primary and secondary consequences on skeletal metabolism and probably depend on the complex interplay of a number of factors derived from tumour tissues. An improved understanding of these interactions may lead to new approaches in the management of these common disorders.
References
1.
Elomaa I, Blomqvist C, Grohn P, Porkka L, Kairento A, Selander K
. Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases. Lancet. 1983; 1(8317):146-9.
DOI: 10.1016/s0140-6736(83)92755-1.
View
2.
Ralston S, Fogelman I, Gardner M, Boyle I
. Hypercalcaemia and metastatic bone disease: is there a causal link?. Lancet. 1982; 2(8304):903-5.
DOI: 10.1016/s0140-6736(82)90868-6.
View
3.
Josse R, Murray T, Mundy G, Jez D, Heersche J
. Observations on the mechanism of bone resorption induced by multiple myeloma marrow culture fluids and partially purified osteoclast-activating factor. J Clin Invest. 1981; 67(5):1472-81.
PMC: 370715.
DOI: 10.1172/jci110177.
View
4.
LONGMIRE Jr W
. Gastric carcinoma: is radical gastrectomy worth while?. Ann R Coll Surg Engl. 1980; 62(1):25-30.
PMC: 2492281.
View
5.
Galasko C
. Skeletal metastases and mammary cancer. Ann R Coll Surg Engl. 1972; 50(1):3-28.
PMC: 2388058.
View